didi_ : the usual pump up and dump after all the suckers came in
Tangerine11 : Orphazyme announces publication of results from its Phase 2/3 trial of arimoclomol in Niemann-Pick disease type C in the Journal of Inherited Metabolic Disease
Tangerine11 : Arimoclomol was well-tolerated with a statistically significant and clinically meaningful effect on disease progression
didi_ : the usual pump up and dump after all the suckers came in
Tangerine11 : Orphazyme announces publication of results from its Phase 2/3 trial of arimoclomol in Niemann-Pick disease type C in the Journal of Inherited Metabolic Disease
Tangerine11 : Arimoclomol was well-tolerated with a statistically significant and clinically meaningful effect on disease progression